FDA Restricts Clinical Trial Review Board Over Safety
Institutional review board Coast IRB LLC agreed Tuesday to stop reviewing new research studies regulated by the U.S Food and Drug Administration, after the agency expressed serious concerns over whether the...To view the full article, register now.
Already a subscriber? Click here to view full article